More from these Authors

• Article | Journal of Management Studies | December 2020

  What Has Changed? The Impact of COVID Pandemic on the Technology and Innovation Management Research Agenda

  Gerard George, Karim R. Lakhani and Phanish Puranam

  Whereas the pandemic has tested the agility and resilience of organizations, it forces a deeper look at the assumptions underlying theoretical frameworks that guide managerial decisions and organizational practices. In this commentary, we explore the impact of the COVID-19 pandemic on technology and innovation management research. We identify key assumptions, and then, discuss how new areas of investigation emerge based on the changed reality.

  Keywords: COVID-19; Health Pandemics; Technology; Innovation and Management; Research;

  Citation:

  George, Gerard, Karim R. Lakhani, and Phanish Puranam. "What Has Changed? The Impact of COVID Pandemic on the Technology and Innovation Management Research Agenda." doi:10.1111/joms.12634. Journal of Management Studies 57, no. 8 (December 2020).  View Details

  CiteView Details Read Now

  Related

• Case | HBS Case Collection | September 2020 (Revised October 2020)

  Moderna (A)

  Marco Iansiti, Karim R. Lakhani, Hannah Mayer and Kerry Herman

  In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19. The case explores how a company builds a digital organization, and leverages artificial intelligence and other digital resources to speed its operations, manage its processes and ensure quality across research, testing and manufacturing.
  Built from the ground up as such a digital organization, Moderna was able to respond to the challenge of developing a vaccine as soon as the gene sequence for the virus was posted to the Web on January 11, 2020. As the vaccine enters Phase III clinical trials, Bancel considers several issues: How should Bancel and his team balance the demands of developing a vaccine for a virus creating a global pandemic alongside the other important vaccines and therapies in Moderna’s pipeline? How should Moderna communicate its goals and vision to investors in this unprecedented time? Should Moderna be concerned it will be pegged as “a COVID-19 company?”

  Keywords: COVID-19; vaccine; digital organizations; Organizational Structure; Operations; Management; Health Pandemics; Research and Development; Goals and Objectives;

  Citation:

  Iansiti, Marco, Karim R. Lakhani, Hannah Mayer, and Kerry Herman. "Moderna (A)." Harvard Business School Case 621-032, September 2020. (Revised October 2020.)  View Details

  CiteView DetailsEducatorsPurchase

  Related

• Case | HBS Case Collection | October 2020

  Experimentation at Yelp

  Iavor I Bojinov and Karim R. Lakhani

  Citation:

  Bojinov, Iavor I., and Karim R. Lakhani. "Experimentation at Yelp." Harvard Business School Case 621-064, October 2020.  View Details

  CiteView DetailsEducators

  Related